FWS reopened the comment period on its October 18, 2022, proposed rule to list the Kern Canyon slender salamander and the relictual slender salamander under the ESA and to designate critical habitat, in order to allow opportunity for interested parties to comment on the new areas the Agency is considering for relictual slender salamander critical habitat, small changes to Kern Canyon slender salamander critical habitat, and updates to the physical or biological features for the Kern Canyon slender salamander.

EPA announced the availability of and seeks comment on a draft policy that updates the Agency’s 2003 Public Involvement Policy.

EPA announced a 60-day public comment period on the draft revision of the Technical Guidance for Assessing Environmental Justice in Regulatory Analysis.

FWS established a nonessential experimental population of the gray wolf in Colorado under the ESA. 

EPA revised regulations addressing preemption of state and local regulation of locomotives and engines used in locomotives. 

FWS removed the plants island bedstraw and Santa Cruz Island dudleya from the Federal List of Endangered and Threatened Plants on the basis of recovery. 

In order to comply with a district court order, FWS reinstated regulatory protections under the ESA for the gray wolf in all or portions of the 45 U.S. states and Mexico, where the species was listed at the time the delisting rule was issued. 

FWS reclassified Mitracarpus polycladus from endangered to threatened under the ESA, and issued a rule under §4(d) of the Act that provides for the conservation of the species.

FWS proposed to list the oblong rocksnail as an endangered species under the ESA.

EPA announced the availability of three near-term strategies the Agency is taking to further implement its obligations and commitments under the Federal Food, Drug, and Cosmetic Act to screen for and protect against endocrine disrupting effects in humans, and seeks additional endocrine data on two groups of active ingredients currently undergoing registration review.